首都医科大学学报 ›› 2000, Vol. 21 ›› Issue (2): 152-154.

• 论著 • 上一篇    下一篇

81例喉癌疗效分析

李文竹, 张玉书   

  1. 首都医科大学附属北京友谊医院放疗科
  • 收稿日期:1999-07-05 修回日期:1900-01-01 出版日期:2000-04-15 发布日期:2000-04-15

Treatment of Laryngeal Carcinoma: A Report of 81 Cases

Li Wenzhu, Zhang Yushu   

  1. Department of Radiation Oncology, Beijing Friendship Hospital, Affiliate of Capital University of Medical Sciences
  • Received:1999-07-05 Revised:1900-01-01 Online:2000-04-15 Published:2000-04-15

摘要: 为研究单纯放疗及综合治疗对喉癌预后的影响,对81例喉癌患者进行了分析。发现:单纯放疗组和综合治疗组(手术+放疗)的5年生存率分别为51.6%(32/62)及84.2%(16/19),其中Ⅰ、Ⅱ期喉癌单纯放疗组的5年生存率为85%(17/20),略高于综合治疗组的50%(1/2)(P>0.05),Ⅲ、Ⅳ期喉癌综合治疗组的5年生存率为88.2%(15/17),显着高于单纯放疗组的35.7%(15/42)(P<0.05).提示喉癌病例Ⅰ、Ⅱ期应首选放疗方案,Ⅲ、Ⅳ期以综合治疗为佳。

关键词: 喉癌, 放射治疗, 综合治疗

Abstract: To investigate the results of laryngeal carcinoma, 81patients with laryngeal carcinoma treated from Jan.1980 to Jan.1990 received either radiotherapy (R group,62) or surgery plus radiotherapy (S+R group,19).The 5 year survival rates were 51.6%(32/62) and 84.2%(16/19). The 5 year survival rates of stage Ⅰto Ⅱ were 85% (17/20)and 50%(1/2), respectively (P>0.05). The 5 year survival rates of stage Ⅲ to Ⅳ were 35.7(15/42)and 88.2%(15/17)(P<0.05). It was concluded that for early lesions (stage Ⅰ and Ⅱ)of laryngeal carcinoma, radiotherapy are primary used. For advanced lesions (stage Ⅲ and Ⅳ) of laryngeal carcinoma, combined radiotherapy and surgery are preferred.

Key words: laryngeal carcinoma, radiotherapy, combined treatment

中图分类号: